Brief: Tarsus Pharmaceuticals Q4 EPS USD -0.2
23/02/2026 21:05
Feb 23 (Reuters) - Tarsus Pharmaceuticals Q4 net income USD -8.373 million. Q4 revenue USD 151.668 million vs. IBES estimate USD 144.6 million Q4 basic EPS USD -0.2
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)